Search - tctmd.com

Displaying 241 - 260 of 465

Sort: Relevancy | Date

Presentation TCT 2017

Does Left Ventricular Hypertrophy Compromise Coronary Flow Reserve and Affect Intervention Choices?

Presenter: Mark C. Bates, Bernard J. Gersh, Justin E. Davies

October 30, 2017

Presentation TCT 2017

When Should Coronary Disease Be Suspected and Worked Up in Hypertension?

Presenter: Mark C. Bates, Bernard J. Gersh, Farrell O. Mendelsohn

October 30, 2017

Presentation TCT 2017

Why Are Hypertension and Coronary Artery Disease So Connected?

Presenter: Mark C. Bates, Bernard J. Gersh, Suzanne Oparil

October 30, 2017

Presentation TCT 2017

Renal Artery Atherosclerosis and Secondary Hypertension: Frequency, Diagnosis, and Treatment

Presenter: Mark C. Bates, Bernard J. Gersh, Michael R. Jaff

October 30, 2017

Presentation TCT 2017

Uncontrolled Hypertension Management Issues: Adherence, Testing, and Difficult Patient Scenarios

Presenter: Sidney C. Smith, Michael A. Weber

October 30, 2017

Presentation TCT 2017

What is the Optimal Therapy for Hypertension?

Presenter: Sidney C. Smith, Michael A. Weber

October 30, 2017

Presentation TCT 2017

Office, Home, or Ambulatory Blood Pressure: How to Measure Blood Pressure in Practice and Clinical Trials

Presenter: Sidney C. Smith, Michael A. Weber, C. Venkata S. Ram

October 30, 2017

Presentation TCT 2017

New U.S. Hypertension Guidelines and Treatment Targets

Presenter: Sidney C. Smith, Michael A. Weber, Sandra J Taler

October 30, 2017

Presentation TCT 2017

Recent Clinical Trials and Nonrandomized Studies That Will Change Your Daily Practice

Presenter: Sidney C. Smith, Michael A. Weber, Vasilios Papademetriou

October 30, 2017

Presentation TCT 2016

TCT 764: Effects of Multielectrode Renal Denervation on Sympathetic Nerve Activity and Insulin Resistance in Metabolic Syndrome

Presenter: Melvin D. Lobo, Adam Witkowski, Vasilios Papademetriou

October 31, 2016

Presentation TCT 2016

TCT 761: Long-term (Three-Year) Safety and Effectiveness From the Global SYMPLICITY Registry of Renal Denervation in a Real World Patient Population With Uncontrolled Hypertension

Presenter: Melvin D. Lobo, Adam Witkowski

October 31, 2016

Presentation TCT 2016

TCT 763: Alcohol-Mediated Renal Denervation Current Status and Future Directions

Presenter: Melvin D. Lobo, Adam Witkowski

October 31, 2016

Presentation TCT 2016

TCT 762: Renal Denervation Treatment With the Symplicity Spyral Multielectrode Catheter: Six-Month Safety and Blood Pressure Outcomes From the Global SYMPLICITY Registry

Presenter: Melvin D. Lobo, Adam Witkowski

October 31, 2016

Presentation TCT 2016

Beyond Hypertension: Autonomic Modulation Therapies for "Outside the Box" Conditions

Presenter: Elazer R. Edelman, Krishna J. Rocha-Singh, Adam Witkowski

October 30, 2016

Presentation TCT 2016

Beyond Hypertension: Autonomic Modulation Therapies for Arrhythmias

Presenter: Elazer R. Edelman, Krishna J. Rocha-Singh, Vivek Y. Reddy

October 30, 2016

Presentation TCT 2016

Beyond Hypertension: Autonomic Modulation Therapies for Chronic Heart Failure

Presenter: Elazer R. Edelman, Krishna J. Rocha-Singh, Farrell O. Mendelsohn

October 30, 2016

$Median Nerve Stimulation for Refractory Hypertension: Valencia Technologies$

Presentation TCT 2016

Median Nerve Stimulation for Refractory Hypertension: Valencia Technologies

Presenter: Ajay J. Kirtane, Bryan Williams, William B. White

October 30, 2016

Presentation TCT 2016

Pacing-based Treatments of Hypertension: BackBeat Medical

Presenter: Ajay J. Kirtane, Bryan Williams, Karl-Heinz Kuck

October 30, 2016

Presentation TCT 2016

Shunt-based Technologies for Hypertension Control: The Rox Medical Program

Presenter: Ajay J. Kirtane, Bryan Williams, Paul A. Sobotka

October 30, 2016

Presentation TCT 2016

Carotid Barostimulation to Treat Hypertension (Vascular Dynamics): Mobius HD and the CALM Studies

Presenter: Ajay J. Kirtane, Bryan Williams, Wilko Spiering

October 30, 2016

Advertisement

Does Left Ventricular Hypertrophy Compromise Coronary Flow Reserve and Affect Intervention Choices?

When Should Coronary Disease Be Suspected and Worked Up in Hypertension?

Why Are Hypertension and Coronary Artery Disease So Connected?

Renal Artery Atherosclerosis and Secondary Hypertension: Frequency, Diagnosis, and Treatment

Uncontrolled Hypertension Management Issues: Adherence, Testing, and Difficult Patient Scenarios

What is the Optimal Therapy for Hypertension?

Office, Home, or Ambulatory Blood Pressure: How to Measure Blood Pressure in Practice and Clinical Trials

New U.S. Hypertension Guidelines and Treatment Targets

Recent Clinical Trials and Nonrandomized Studies That Will Change Your Daily Practice

TCT 764: Effects of Multielectrode Renal Denervation on Sympathetic Nerve Activity and Insulin Resistance in Metabolic Syndrome

TCT 761: Long-term (Three-Year) Safety and Effectiveness From the Global SYMPLICITY Registry of Renal Denervation in a Real World Patient Population With Uncontrolled Hypertension

TCT 763: Alcohol-Mediated Renal Denervation Current Status and Future Directions

TCT 762: Renal Denervation Treatment With the Symplicity Spyral Multielectrode Catheter: Six-Month Safety and Blood Pressure Outcomes From the Global SYMPLICITY Registry

Beyond Hypertension: Autonomic Modulation Therapies for "Outside the Box" Conditions

Beyond Hypertension: Autonomic Modulation Therapies for Arrhythmias

Beyond Hypertension: Autonomic Modulation Therapies for Chronic Heart Failure

Median Nerve Stimulation for Refractory Hypertension: Valencia Technologies

Pacing-based Treatments of Hypertension: BackBeat Medical

Shunt-based Technologies for Hypertension Control: The Rox Medical Program

Carotid Barostimulation to Treat Hypertension (Vascular Dynamics): Mobius HD and the CALM Studies

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content